<VariationArchive RecordType="classified" VariationID="2504110" VariationName="NM_001754.5(RUNX1):c.1256_1262dup (p.Glu422fs)" VariationType="Duplication" Accession="VCV002504110" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-12-25" DateCreated="2023-06-10" MostRecentSubmission="2023-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2669066" VariationID="2504110">
      <GeneList>
        <Gene Symbol="RUNX1" FullName="RUNX family transcription factor 1" GeneID="861" HGNC_ID="HGNC:10471" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34787801" stop="35049302" display_start="34787801" display_stop="35049302" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36160097" stop="36421594" display_start="36160097" display_stop="36421594" Strand="-" />
          </Location>
          <OMIM>151385</OMIM>
          <Haploinsufficiency last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001754.5(RUNX1):c.1256_1262dup (p.Glu422fs)</Name>
      <CanonicalSPDI>NC_000021.9:34792315:CCGCCCACC:CCGCCCACCGCCCACC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>21q22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34792315" stop="34792316" display_start="34792315" display_stop="34792316" variantLength="7" positionVCF="34792315" referenceAlleleVCF="G" alternateAlleleVCF="GCCGCCCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36164612" stop="36164613" display_start="36164612" display_stop="36164613" variantLength="7" positionVCF="36164612" referenceAlleleVCF="G" alternateAlleleVCF="GCCGCCCA" />
      </Location>
      <OtherNameList>
        <Name>NM_001754.5(RUNX1):c.1256_1262dup</Name>
        <Name>p.Glu422fs</Name>
      </OtherNameList>
      <ProteinChange>E395fs</ProteinChange>
      <ProteinChange>E422fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_482" sequenceAccession="LRG_482">
            <Expression>LRG_482:g.1197390_1197396dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.36164615_36164621dup" Assembly="GRCh37">
            <Expression>NC_000021.8:g.36164615_36164621dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.34792318_34792324dup" Assembly="GRCh38">
            <Expression>NC_000021.9:g.34792318_34792324dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011402.2" sequenceAccession="NG_011402" sequenceVersion="2" change="g.1197390_1197396dup">
            <Expression>NG_011402.2:g.1197390_1197396dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001001890.3" sequenceAccession="NM_001001890" sequenceVersion="3" change="c.1175_1181dup">
            <Expression>NM_001001890.3:c.1175_1181dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001001890.1" sequenceAccession="NP_001001890" sequenceVersion="1" change="p.Glu395fs">
            <Expression>NP_001001890.1:p.Glu395fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001754.5" sequenceAccession="NM_001754" sequenceVersion="5" change="c.1256_1262dup" MANESelect="true">
            <Expression>NM_001754.5:c.1256_1262dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001745.2" sequenceAccession="NP_001745" sequenceVersion="2" change="p.Glu422fs">
            <Expression>NP_001745.2:p.Glu422fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001754.4" sequenceAccession="NM_001754" sequenceVersion="4" change="c.1256_1262dup">
            <Expression>NM_001754.4:c.1256_1262dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_482t1" sequenceAccession="LRG_482t1">
            <Expression>LRG_482t1:c.1254_1260dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_482p1" sequenceAccession="LRG_482p1" change="p.Glu422Glyfs">
            <Expression>LRG_482p1:p.Glu422Glyfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001754.5(RUNX1):c.1256_1262dup (p.Glu422fs) AND Atypical chronic myeloid leukemia, BCR-ABL1 negative" Accession="RCV003232902" Version="1">
        <ClassifiedConditionList TraitSetID="19831">
          <ClassifiedCondition DB="MedGen" ID="C1292772">Atypical chronic myeloid leukemia, BCR-ABL1 negative</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-04-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001754.5(RUNX1):c.1256_1262dup (p.Glu422fs) AND Hereditary thrombocytopenia and hematologic cancer predisposition syndrome" Accession="RCV003448491" Version="1">
        <ClassifiedConditionList TraitSetID="54065">
          <ClassifiedCondition DB="MedGen" ID="CN281654">Hereditary thrombocytopenia and hematologic cancer predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2023-12-09" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-09" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-06-10" MostRecentSubmission="2023-12-17">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/d265ba4b-1394-43c7-96e1-4d96dabc4fbc</URL>
        </Citation>
        <DescriptionHistory Dated="2023-12-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="54065" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="53344" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary thrombocytopenia and hematologic cancer predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0011071" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10352" />
                <XRef ID="10352" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="71290" DB="Orphanet" />
              <XRef ID="CN281654" DB="MedGen" />
              <XRef ID="MONDO:0011071" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="19831" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17744" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Atypical chronic myeloid leukemia</ElementValue>
                <XRef ID="13-00656" DB="NCBI for submitter" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Atypical chronic myeloid leukemia, BCR-ABL1 negative</ElementValue>
                <XRef ID="MONDO:0004653" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACML</ElementValue>
                <XRef ID="608232" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19583" />
                <XRef ID="19583" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/cml.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Chronic Myeloid Leukemia, 2023</CitationText>
              </Citation>
              <XRef ID="98824" DB="Orphanet" />
              <XRef ID="C1292772" DB="MedGen" />
              <XRef ID="MONDO:0004653" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7345129" SubmissionDate="2023-05-30" DateLastUpdated="2023-06-10" DateCreated="2023-06-10">
        <ClinVarSubmissionID localKey="NM_001754.4:c.1256_1262dup|MONDO:MONDO:0004653" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003929447" DateUpdated="2023-06-10" DateCreated="2023-06-10" Type="SCV" Version="1" SubmitterName="Institute of Laboratory Medicine, Hospital Wels-Grieskirchen" OrgID="509117" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <GeographicOrigin>Austria;Europe</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">60</Age>
              <Age Type="maximum" age_unit="years">69</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001754.4:c.1256_1262dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0004653" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13480971</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="7814813" SubmissionDate="2023-12-11" DateLastUpdated="2023-12-17" DateCreated="2023-12-17">
        <ClinVarSubmissionID localKey="d265ba4b-1394-43c7-96e1-4d96dabc4fbc" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004176260" DateUpdated="2023-12-17" DateCreated="2023-12-17" Type="SCV" Version="1" SubmitterName="ClinGen Myeloid Malignancy Variant Curation Expert Panel" OrgID="507107" OrganizationCategory="consortium" OrgAbbreviation="MyeloMalig_VCEP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-09">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/d265ba4b-1394-43c7-96e1-4d96dabc4fbc</URL>
          </Citation>
          <Comment>The c.1256_1262dup (p.Glu422Glyfs*180)(NM_001754.5) variant is a frameshift duplication in RUNX1 - whose mechanism of disease is established to be loss-of-function - that is predicted to escape nonsense mediated decay but alter a functionally important region (transactivation domain, inhibitory domain, and/or the VWRPY motif) (PVS1_Strong). In addition, the variant is expected to result in a protein extension with a new stop codon at c.*351_*353, which is upstream of RUNX1's poly-A recognition and insertion sites (c.*3831_*3836 | c.*3850 and c.*4304_*4309 | c.*4334), and thus, non-stop decay is also not predicted. Furthermore, although this variant has not been published in patients, other pathogenic/likely pathogenic frameshift alterations in exon 8 have been reported (PMID: 35764482), and it may be of note that some RUNX1 frameshift elongation variants have been described with a dominant negative effect (PMID: 28855357) (PM5_Supporting). Finally, this variant is absent from gnomAD v2, v3, and v4 (PM2_Supporting). In summary, this variant meets the criteria to be classified as a likely pathogenic for autosomal dominant hereditary thrombocytopenia and hematologic cancer predisposition syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy VCEP: PVS1_Strong, PM2_Supporting, and PM5_Supporting. (Version 2; date of approval)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen MyeloMalig ACMG Specifications v2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/g9fkgwq9/clingen_myelomalig_acmg_specifications_v2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001754.5(RUNX1):c.1256_1262dup</Name>
            <Name>p.Glu422fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.9:g.34792318_34792324dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0011071" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14033059</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7814813" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0011071" MappingRef="MONDO">
        <MedGen CUI="CN281654" Name="Hereditary thrombocytopenia and hematologic cancer predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7345129" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0004653" MappingRef="MONDO">
        <MedGen CUI="C1292772" Name="Atypical chronic myeloid leukemia, BCR-ABL1 negative" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

